Future DTC drug ads will be hyper-targeted

04/2/2012 | Medical Marketing & Media

As big pharma's focus shifts from creating blockbusters to developing biologic drugs and other niche products, drug marketing will become more narrow, targeted and multifaceted, writes Matthew Arnold. For example, AbelsonTaylor's campaign for Pfizer and Amgen's Enbrel features a celebrity spokesman, but a separate campaign for the therapy targets patients with plaque psoriasis. New measurement and analysis tools, as well as consumer channels, allow marketers to reach potential patients with more precision, experts say.

View Full Article in:

Medical Marketing & Media

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA